NCT02016261

Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Open Label, Non-comparative Study to Evaluate Cognitive Functioning in Remitted Depression Outpatients During Long-term Preventive Treatment With Fluvoxamine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Moscow Research Institute of Psychiatry · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Open label, non-comparative, prospective study to evaluate cognitive functioning in remitted depression outpatients during long-term preventive treatment with Fluvoxamine (Fevarin®)

Conditions

• Recurrent Depressive Disorder

Interventions

Type	Name	Description
DRUG	Fluvoxamine	The subjects will be prescribed Fluvoxamine treatment for 24 weeks with dose 50-300 mg

Timeline

• Start date: 2013-12-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2013-12-19
• Last updated: 2015-07-21

Locations

1 site across 1 country: Russia